EMZ702

Thuốc Gốc

Small Molecule

EMZ702, a non-toxic agent that has strong anti-viral synergy with interferon, is an ideal candidate for combination with current standard hepatitis C treatments. EMZ702 has an excellent safety profile and the combination of EMZ702 with interferon and ribavirin in surrogate models for hepatitis C has demonstrated a two to three fold increase in anti-viral potency compared to interferon and ribavirin alone.

Chỉ Định : Investigated for use/treatment in hepatitis (viral, C).

Tài Liệu Tham Khảo Thêm

drugbank

http://www.drugbank.ca/drugs/DB05021

Bạn thấy hài lòng ?

Bạn chưa hài lòng ?

... loading